Skip to content
Press Release

UgenTec is now part of Velsera

Boston, San Francisco, Stockholm – January 12, 2023

UgenTec & PathoFinder announce rollout of multiplex PCR interpretation software

UgenTec & PathoFinder have successfully rolled out the interpretation solution for PathoFinder’s next generation multiplex PCR 2SMART assays.

UgenTec & SpeeDx announce collaboration on artificially intelligent analysis plugin for ResistancePlus™ MG test

UgenTec NV, the European bio-informatics company that develops artificially intelligent PCR interpretation software, and SpeeDx Pty. Ltd., a developer...

Load more
Start with FastFinder
Copyright 2024
  • Kempische Steenweg 303/105, 3500 Hasselt Belgium (map)
  • 1 Mifflin Place, Suite 400 Cambridge, MA 02138, USA (map)
Contact: info@ugentec.com | +32 78 48 44 79 | VAT number: BE05 5197 6421